Lidia Oostvogels is a MD with over 25 years of global clinical development expertise, of which 17 in development of Prophylactic Vaccines. As Therapeutic Area Head Infectious Diseases, she leads the clinical development/medical team and overviews the strategy for the Area of Infectious Diseases in Curevac, which she joined in 2018. Prior to moving to CureVac, she was leading vaccine clinical teams in the Belgian Clinical R&D center at GSK, including the Shingrix clinical team. At the mRNA conference, she will present most recent data, including clinical data, from CureVacs  Prophylactic Vaccine development programs.